AHA Invests in AI that Tackles Cardiology’s Gender Bias Problem

The American Heart Association is backing an AI startup aimed at improving detection of hard-to-diagnose conditions like cardiac amyloidosis and heart failure with preserved ejection fraction (HFpEF). The company, named Ultromics, offers a platform that analyzes routine echocardiograms to help clinicians catch disease earlier, particularly for women who are more likely to be missed. The…

Read More

Links

How do companies decide which drugs to develop?“attending a more selective college causally reduces obesity”28% of patients with HIV were covered by MedicareThe AI Scientist + End-to-end causal effect estimation Development approval timelines and new housing supply in LA

Read More

Wearable Noise Is Exploding — Trust Is the Filter

The challenge is determining whether wearable data is reliable enough to relieve the review burden, guide care, support reimbursement, or reassure a patient who is worried about their heart rhythm at two o’clock in the morning. The post Wearable Noise Is Exploding — Trust Is the Filter appeared first on MedCity News.

Read More

How One Startup Is Aiming to Replace Surgery with Its Endometriosis Diagnostic

Heranova Lifesciences recently launched a noninvasive blood test to diagnose endometriosis. The standard diagnostic method is laparoscopy, which requires anesthesia, followed by histological confirmation. With its blood test, Heranova seeks to replace the diagnostic function of laparoscopy, thus reserving surgical intervention only for therapeutic purposes. The post How One Startup Is Aiming to Replace Surgery…

Read More